Raising capital through Crowdfunding will be challenging for life science companies given the industry's capital intensity and investor preference for liquidity (drug development associated with long approval timelines). S. Jordan Associates (SJA), a Chicago-based life sciences consultant/investment bank, advises emerging growth biotechnology companies on viable pathways for raising funding through Crowdfunding and has published research on the topic.
Research illustrating viable Crowdfunding structures for life science companies is available here.
For more information on Crowdfunding:
